Old Web
English
Sign In
Acemap
>
authorDetail
>
Robert J Laliberte
Robert J Laliberte
Medicine
Javelin
Avelumab
urothelial carcinoma
first line
3
Papers
29
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
MP41-12 AVELUMAB FIRST-LINE MAINTENANCE PLUS BEST SUPPORTIVE CARE VS BEST SUPPORTIVE CARE ALONE FOR ADVANCED UROTHELIAL CARCINOMA: ANALYSIS OF TIME TO END OF NEXT-LINE THERAPY IN JAVELIN BLADDER 100
2021
The Journal of Urology
Petros Grivas
Se Hoon Park
Eric Voog
Evgeny Kopyltsov
Howard Gurney
David Queiroz Borges Muniz
Frederic Rolland
Anne Birgitte Als
Begoña P. Valderrama
Jing Wang
Nuno Costa
Robert J Laliberte
Alessandra di Pietro
Thomas Powles
Joaquim Bellmunt
Show All
Source
Cite
Save
Citations (0)
PD55-01 AVELUMAB FIRST-LINE MAINTENANCE FOR ADVANCED UROTHELIAL CARCINOMA IN THE JAVELIN BLADDER 100 TRIAL: SUBGROUP ANALYSIS BY DURATION OF TREATMENT-FREE INTERVAL FROM END OF CHEMOTHERAPY TO START OF MAINTENANCE
2021
The Journal of Urology
Srikala S. Sridhar
Thomas Powles
Yohann Loriot
Miguel Ángel Climent Duran
Shilpa Gupta
Norihiko Tsuchiya
Aristotelis Bamias
Andrea Ardizzoni
Anders Ullén
Bo Huang
Nuno Costa
Robert J Laliberte
Alessandra di Pietro
Cora N. Sternberg
Petros Grivas
Show All
Source
Cite
Save
Citations (0)
CDX-1307: a novel vaccine under study as treatment for muscle-invasive bladder cancer
2011
Expert Review of Vaccines
Michael A. Morse
Deborah Bradley
Tibor Keler
Robert J Laliberte
Jennifer Green
Thomas A. Davis
Brant A. Inman
Show All
Source
Cite
Save
Citations (29)
1